给17名健康妇女短期服用新复方避孕药[含0.150mg地索高诺酮和20m(?)g炔雌醇(EE)],用药1,3,6个月以后,将随访情况列表,评价其所有临床项目。在末次自然月经周期的第18和21天之间以及用药6个月时,收集所有人的血样,用于测定纤维蛋白A(FPA)。为了评价脂代谢和碳水化合物代谢方面的作用,收集用药前和用药6个月的血样,测定血糖、胰岛素、糖基化血红蛋白 Seventeen healthy women were given short-term new contraceptives [0.150 mg desopogon and 20 mg ethinylestradiol (EE)] for 1, 3 and 6 months after treatment. The follow-up status was evaluated and evaluated All of its clinical projects. All human blood samples were collected for determination of fibrin A (FPA) between days 18 and 21 of the last natural menstrual cycle and 6 months of dosing. In order to evaluate the effects of lipid metabolism and carbohydrate metabolism, blood samples were collected 6 months before and 6 months after administration, and blood glucose, insulin, glycosylated hemoglobin